We estimate that the CEO of NATIONAL HEALTH INVESTORS INC ($NHI), D. Eric Mendelsohn, received a compensation of $3,652,795 in 2025. This is an increase of 38.5% from an estimated $2,246,596 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 03, 2026. Note that parsing errors may occur.
You can track $NHI on Quiver Quantitative's $NHI stock dashboard.
$NHI Stock Congressional Stock Trading
Members of Congress have traded $NHI stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $NHI stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 01/15.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$NHI Stock Hedge Fund Activity
We have seen 150 institutional investors add shares of $NHI Stock stock to their portfolio, and 106 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MACQUARIE GROUP LTD removed 929,361 shares (-95.0%) from their portfolio in Q4 2025, for an estimated $70,975,299
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 711,457 shares (-75.2%) from their portfolio in Q4 2025, for an estimated $54,333,971
- JPMORGAN CHASE & CO removed 626,307 shares (-38.8%) from their portfolio in Q4 2025, for an estimated $47,831,065
- FREESTONE GROVE PARTNERS LP added 286,355 shares (+inf%) to their portfolio in Q4 2025, for an estimated $21,868,931
- BALYASNY ASSET MANAGEMENT L.P. removed 277,068 shares (-67.8%) from their portfolio in Q4 2025, for an estimated $21,159,683
- PRUDENTIAL FINANCIAL INC added 266,858 shares (+36.3%) to their portfolio in Q4 2025, for an estimated $20,379,945
- CENTERSQUARE INVESTMENT MANAGEMENT LLC added 167,352 shares (+17.0%) to their portfolio in Q4 2025, for an estimated $12,780,672
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NHI Stock Analyst Ratings
Wall Street analysts have issued reports on $NHI in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 12/16/2025
- Keybanc issued a "Overweight" rating on 12/04/2025
To track analyst ratings and price targets for $NHI Stock, check out Quiver Quantitative's $NHI forecast page.
$NHI Stock Price Targets
Multiple analysts have issued price targets for $NHI recently. We have seen 3 analysts offer price targets for $NHI in the last 6 months, with a median target of $88.0.
Here are some recent targets:
- John Kilichowski from Wells Fargo set a target price of $86.0 on 03/27/2026
- Michael Lewis from Truist Securities set a target price of $92.0 on 03/12/2026
- Todd M. Thomas from Keybanc set a target price of $88.0 on 12/04/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
